TY - JOUR
T1 - Later-onset fabry disease
T2 - An adult variant presenting with the cramp-fasciculation syndrome
AU - Nance, Christopher S.
AU - Klein, Christopher J.
AU - Banikazemi, Maryam
AU - Dikman, Steven H.
AU - Phelps, Robert G.
AU - McArthur, Justin C.
AU - Rodriguez, Moses
AU - Desnick, Robert J.
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2006/3
Y1 - 2006/3
N2 - Background: Classic Fabry disease, an X-linked recessive lysosomal storage disease due to the deficient activity of α-galactosidase A, typically presents in early childhood with acroparesthesias, angiokeratomas, hypohidrosis, and corneal dystrophy. The neuropathic pain presumably results from glycosphingolipid accumulation in the vascular endothelium and in small-caliber nerve fibers, and is treatable by enzyme replacement therapy. Later-onset variants with residual α-galactosidase A activity lack vascular endothelial involvement and classic symptoms, which lead to the development of cardiac and/or renal disease after the fourth decade of life. Objective: To expand the later-onset Fabry phenotype to include cramp-fasciculation syndrome without small-fiber neuropathy. Methods: A 34-year-old man who presented with chronic exercise-induced pain, fasciculations, and cramps of the feet and legs, and his similarly affected mother, were evaluated. Clinical, biochemical, and molecular studies were performed. Results: Clinical evaluation suggested the diagnosis of Fabry disease, which was confirmed by reduced plasma and leukocyte α-galactosidase A activities (8.8% and 13.4% of normal, respectively) due to a missense A143T mutation. His mother was heterozygous for the A143T mutation. Conclusion: The presentation of cramps and fasciculations without apparent small-fiber neuropathy expands the phenotype of later-onset Fabry disease.
AB - Background: Classic Fabry disease, an X-linked recessive lysosomal storage disease due to the deficient activity of α-galactosidase A, typically presents in early childhood with acroparesthesias, angiokeratomas, hypohidrosis, and corneal dystrophy. The neuropathic pain presumably results from glycosphingolipid accumulation in the vascular endothelium and in small-caliber nerve fibers, and is treatable by enzyme replacement therapy. Later-onset variants with residual α-galactosidase A activity lack vascular endothelial involvement and classic symptoms, which lead to the development of cardiac and/or renal disease after the fourth decade of life. Objective: To expand the later-onset Fabry phenotype to include cramp-fasciculation syndrome without small-fiber neuropathy. Methods: A 34-year-old man who presented with chronic exercise-induced pain, fasciculations, and cramps of the feet and legs, and his similarly affected mother, were evaluated. Clinical, biochemical, and molecular studies were performed. Results: Clinical evaluation suggested the diagnosis of Fabry disease, which was confirmed by reduced plasma and leukocyte α-galactosidase A activities (8.8% and 13.4% of normal, respectively) due to a missense A143T mutation. His mother was heterozygous for the A143T mutation. Conclusion: The presentation of cramps and fasciculations without apparent small-fiber neuropathy expands the phenotype of later-onset Fabry disease.
UR - http://www.scopus.com/inward/record.url?scp=33644895723&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33644895723&partnerID=8YFLogxK
U2 - 10.1001/archneur.63.3.453
DO - 10.1001/archneur.63.3.453
M3 - Article
C2 - 16533976
AN - SCOPUS:33644895723
SN - 0003-9942
VL - 63
SP - 453
EP - 457
JO - Archives of Neurology
JF - Archives of Neurology
IS - 3
ER -